Loading...
Loading...
Shares of Tekmira Pharmaceuticals TKMR are up six percent in Monday’s pre-market trading following commentary by Leerink partners.
Leerink initiated coverage at Outperform and assigned a $25 price target.
Monday’s rally follows a 50 percent peak to trough selloff last week and 10 percent climb Friday.
Shares of Tekmira were last trading at $19.25, up 6.47 percent.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in